Here’s an inside look at my small-cap portfolio & the reasons behind each of my holdings as we head into 2025  🧐

• $ASTS -- The American Tower of Space, building a global satellite-to-cellphone network to address the $1T+ connectivity market.

• $RKLB -- The FedEx of Space, providing end-to-end satellite launch, manufacturing & space data solutions for the $400B space economy.

• $IONQ -- Positioning itself as a leader in quantum computing by offering scalable, trapped-ion quantum systems for high-value use cases such as drug discovery, logistics optimization & financial modeling -- addressing a projected $65B quantum computing market by 2030.

• $JMIA -- Building a comprehensive logistics & fintech ecosystem to drive e-commerce growth in Africa -- targeting the continent’s underpenetrated $75B online retail market.

• $EOSE -- Developing zinc-based long-duration energy storage systems for grid-scale renewable energy -- targeting a $3B market opportunity in renewable integration and storage.

• $ENVX -- Innovating next-generation lithium-ion battery designs for consumer electronics & EVs -- targeting a $90B battery market as demand for energy-dense and durable solutions grows.

• $AEHR -- Driving the adoption of silicon carbide (SiC) technology with proprietary test systems that support scaling in EV manufacturing, AI data centers & renewable energy industries.

• $NVTS -- Redefining power efficiency in EVs, 5G & renewable energy markets through advanced gallium nitride (GaN) semiconductors -- targeting faster adoption in the $1B GaN market.

• $INDI -- Delivering system-on-chip (SoC) semiconductor solutions tailored for the growing demand in advanced driver-assistance systems (ADAS) & EVs. 

• $RXRX -- Leveraging AI-driven drug discovery to streamline pharmaceutical R&D, targeting breakthrough treatments & partnerships in the $1.5T global drug market.

• $VKTX -- Advancing late-stage clinical programs in metabolic disorders like NASH & obesity, with a pipeline focused on unlocking multi-billion-dollar opportunities in the endocrine therapeutics market.

• $NTLA -- Developing transformative CRISPR-based therapies, with initial programs targeting multi-billion-dollar markets in genetic diseases such as sickle cell anemia & hereditary ATTR amyloidosis.

• $ONDS -- Powering drones & industrial IoT with private wireless networks, targeting utilities, logistics, agriculture & the $100B+ connectivity market.

• $BEAM -- Developing precision gene-editing technologies using base-editing techniques to target genetic disorders -- positioning itself for a share in the $5B gene therapy market.

• $DCTH -- Pioneering hepatic artery infusion (HAI) therapies for liver cancer, with its flagship product poised to address unmet needs in a $3B global market.

• $DNA -- Expanding its synthetic biology platform to enable cost-efficient cell programming for industries including biopharma, agriculture & manufacturing -- addressing a TAM exceeding $100B.

• $FSLY -- Providing edge cloud infrastructure for real-time processing, security & delivery in e-commerce, fintech & SaaS -- addressing a $15B market.

• $NNOX -- Transforming medical imaging with cost-effective digital X-ray technology aimed at broadening access to diagnostic imaging in a $30B global market.

• $RXST -- Focusing on innovative solutions in urology and endoscopy, with a growing presence in minimally invasive medical devices for an $8B addressable market.